Academic Journal
Vipidia is a new dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes
| Τίτλος: | Vipidia is a new dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes |
|---|---|
| Συγγραφείς: | T. B. Morgunova, V. V. Fadeev |
| Πηγή: | Медицинский совет, Vol 0, Iss 2, Pp 66-69 (2015) |
| Στοιχεία εκδότη: | Remedium Group LLC, 2015. |
| Έτος έκδοσης: | 2015 |
| Συλλογή: | LCC:Medicine |
| Θεματικοί όροι: | сахарный диабет, сахароснижающие препараты, гликемия, инкретин, глюкагоноподобный пептид-1, випидия, diabetes mellitus, hypoglycemic agents, glycemia, incretin, glucagon-like peptide-1, vipidia, Medicine |
| Περιγραφή: | The global number of patients with diabetes mellitus (DM) has been growing steadily. Over the past decade, the number has more than doubled and reached 371 million people by 2013. [1] In most cases it is type 2 diabetes. The dangerous consequences of DM include micro- and macrovascular complications: nephropathy, retinopathy, lesions of the major blood vessels in the heart, brain and lower limbs. Late complications of DM are a major cause of disability and mortality of the patients. |
| Τύπος εγγράφου: | article |
| Περιγραφή αρχείου: | electronic resource |
| Γλώσσα: | Russian |
| ISSN: | 2079-701X 2658-5790 |
| Relation: | https://www.med-sovet.pro/jour/article/view/122; https://doaj.org/toc/2079-701X; https://doaj.org/toc/2658-5790 |
| DOI: | 10.21518/2079-701X-2015-2-66-69 |
| Σύνδεσμος πρόσβασης: | https://doaj.org/article/35b84b4da44e45aea203c9b7a59c5bcb |
| Αριθμός Καταχώρησης: | edsdoj.35b84b4da44e45aea203c9b7a59c5bcb |
| Βάση Δεδομένων: | Directory of Open Access Journals |
| ISSN: | 2079701X 26585790 |
|---|---|
| DOI: | 10.21518/2079-701X-2015-2-66-69 |